These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 19705995)

  • 21. Inflammatory events in hippocampal slice cultures prime neuronal susceptibility to excitotoxic injury: a crucial role of P2X7 receptor-mediated IL-1beta release.
    Bernardino L; Balosso S; Ravizza T; Marchi N; Ku G; Randle JC; Malva JO; Vezzani A
    J Neurochem; 2008 Jul; 106(1):271-80. PubMed ID: 18384650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. P2X7 receptor antagonists: a patent review (2010-2015).
    Park JH; Kim YC
    Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological activity of N-arylpiperazine-modified analogues of KN-62, a potent antagonist of the purinergic P2X7 receptor.
    Baraldi PG; del Carmen Nuñez M; Morelli A; Falzoni S; Di Virgilio F; Romagnoli R
    J Med Chem; 2003 Apr; 46(8):1318-29. PubMed ID: 12672232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The P2X7 purinergic receptor: from physiology to neurological disorders.
    Skaper SD; Debetto P; Giusti P
    FASEB J; 2010 Feb; 24(2):337-45. PubMed ID: 19812374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A cyclic pathway of P2 × 7, bradykinin, and dopamine receptor activation induces a sustained articular hyperalgesia in the knee joint of rats.
    Teixeira JM; Parada CA; Tambeli CH
    Inflamm Res; 2018 Apr; 67(4):301-314. PubMed ID: 29260240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation of P2X7 receptors elevates Ca2+ and kills retinal ganglion cells.
    Zhang X; Zhang M; Laties AM; Mitchell CH
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2183-91. PubMed ID: 15914640
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cloning and pharmacological characterization of the guinea pig P2X7 receptor orthologue.
    Fonfria E; Clay WC; Levy DS; Goodwin JA; Roman S; Smith GD; Condreay JP; Michel AD
    Br J Pharmacol; 2008 Feb; 153(3):544-56. PubMed ID: 18037910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. P2 purinergic receptors signal to STAT3 in astrocytes: Difference in STAT3 responses to P2Y and P2X receptor activation.
    Washburn KB; Neary JT
    Neuroscience; 2006 Oct; 142(2):411-23. PubMed ID: 16905269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling.
    Seiffert K; Ding W; Wagner JA; Granstein RD
    J Invest Dermatol; 2006 May; 126(5):1017-27. PubMed ID: 16410784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P2X7-like receptor activation in astrocytes increases chemokine monocyte chemoattractant protein-1 expression via mitogen-activated protein kinase.
    Panenka W; Jijon H; Herx LM; Armstrong JN; Feighan D; Wei T; Yong VW; Ransohoff RM; MacVicar BA
    J Neurosci; 2001 Sep; 21(18):7135-42. PubMed ID: 11549724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extracellular ATP and the P2X7 receptor in astrocyte-mediated motor neuron death: implications for amyotrophic lateral sclerosis.
    Gandelman M; Peluffo H; Beckman JS; Cassina P; Barbeito L
    J Neuroinflammation; 2010 Jun; 7():33. PubMed ID: 20534165
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cross talk between P2 purinergic receptors modulates extracellular ATP-mediated interleukin-10 production in rat microglial cells.
    Seo DR; Kim SY; Kim KY; Lee HG; Moon JH; Lee JS; Lee SH; Kim SU; Lee YB
    Exp Mol Med; 2008 Feb; 40(1):19-26. PubMed ID: 18305394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microglial phagocytosis attenuated by short-term exposure to exogenous ATP through P2X receptor action.
    Fang KM; Yang CS; Sun SH; Tzeng SF
    J Neurochem; 2009 Dec; 111(5):1225-37. PubMed ID: 19860838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [3H]A-804598 ([3H]2-cyano-1-[(1S)-1-phenylethyl]-3-quinolin-5-ylguanidine) is a novel, potent, and selective antagonist radioligand for P2X7 receptors.
    Donnelly-Roberts DL; Namovic MT; Surber B; Vaidyanathan SX; Perez-Medrano A; Wang Y; Carroll WA; Jarvis MF
    Neuropharmacology; 2009 Jan; 56(1):223-9. PubMed ID: 18602931
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Purinergic receptor regulation of LPS-induced signaling and pathophysiology.
    Guerra AN; Fisette PL; Pfeiffer ZA; Quinchia-Rios BH; Prabhu U; Aga M; Denlinger LC; Guadarrama AG; Abozeid S; Sommer JA; Proctor RA; Bertics PJ
    J Endotoxin Res; 2003; 9(4):256-63. PubMed ID: 12935357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purinergic Receptors in Thrombosis and Inflammation.
    Hechler B; Gachet C
    Arterioscler Thromb Vasc Biol; 2015 Nov; 35(11):2307-15. PubMed ID: 26359511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antagonist effects on human P2X(7) receptor-mediated cellular accumulation of YO-PRO-1.
    Michel AD; Kaur R; Chessell IP; Humphrey PP
    Br J Pharmacol; 2000 Jun; 130(3):513-20. PubMed ID: 10821778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence for the involvement of endogenous ATP and P2X receptors in TMJ pain.
    Oliveira MC; Parada CA; Veiga MC; Rodrigues LR; Barros SP; Tambeli CH
    Eur J Pain; 2005 Feb; 9(1):87-93. PubMed ID: 15629879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P2X7 antagonists for CNS indications: recent patent disclosures.
    Pevarello P; Bovolenta S; Tarroni P; Za L; Severi E; Torino D; Vitalone R
    Pharm Pat Anal; 2017 Mar; 6(2):61-76. PubMed ID: 28248151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanism of action of species-selective P2X(7) receptor antagonists.
    Michel AD; Ng SW; Roman S; Clay WC; Dean DK; Walter DS
    Br J Pharmacol; 2009 Apr; 156(8):1312-25. PubMed ID: 19309360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.